跳到主要內容

Subramaniam Somu 的 Form 4 申報

Ventyx Biosciences, Inc.(VTYX),2023/6/8 申報

申報編號
0000899243-23-015024
申報時間
2023/6/8
交易日
2023/6/6-6/7
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $142.3 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Subramaniam SomuCIK 0001508910董事、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/6/6Common StockS賣出處分−4,128$35.00F1−$144,4809,872,917間接
2023/6/7Common StockS賣出處分−25,801$35.48F7−$915,419.489,847,116間接
2023/6/7Common StockS賣出處分−10,071$36.10F8−$363,563.19,837,045間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Represents the weighted average share price of an aggregate total of 4,128 shares sold in the price range of $35.00 to $35.02. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents the weighted average share price of an aggregate total of 25,801 shares sold in the price range of $35.00 to $35.99. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents the weighted average share price of an aggregate total of 10,071 shares sold in the price range of $36.00 to $36.125. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)